Valuation
- Market cap
- 5,114,000
- Revenue TTM
- $43,870,000
- Net income TTM
- $-2,840,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- -6.47%
- Debt to equity
- 0.00
Trading
- Volume
- 2,000
- Avg volume
- 13,032
- Day's range
- $0.17 – $0.17
- Shares out
- 30,975,000
- Stochastic %K
- 1%
- Beta
- 0.49
- Analysts
- —
- Price target
- —
Company profile
Integrated BioPharma, Inc., together with its subsidiaries, engages in the manufacturing, distributing, marketing and sale of vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. The company operates through two segments, Contract Manufacturing and Other Business Lines. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to dis...
Show more
Integrated BioPharma, Inc., together with its subsidiaries, engages in the manufacturing, distributing, marketing and sale of vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. The company operates through two segments, Contract Manufacturing and Other Business Lines. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment provides warehousing and fulfilment services; and distributes raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey.
- Industry
- Packaged Foods
- Sector
- Consumer Defensive
- Phone
- 888 319 6962
- Website
- https://ir.ibiopharma.com
- Address
- Building 15, 225 Long Avenue, Hillside, United States
Latest news
No headlines yet.
